Clotrimazole/diclofenac - ProFem

Drug Profile

Clotrimazole/diclofenac - ProFem

Alternative Names: Candiplus; Clotrimazole/diclofenac sodium; ProF 001

Latest Information Update: 20 Nov 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator ProFem
  • Class Antifungals; Imidazoles; Non-opioid analgesics; Nonsteroidal anti-inflammatories; Phenylacetates; Small molecules
  • Mechanism of Action 14-alpha demethylase inhibitors; Cell membrane modulators; Cyclooxygenase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No
  • Available For Licensing Yes - Candidiasis

Highest Development Phases

  • Phase II Candidiasis

Most Recent Events

  • 20 Jul 2017 Chemical structure information added
  • 03 Apr 2017 ProF 001 is available for licensing as of 03 Apr 2017.
  • 03 Apr 2017 ProFem has patent protection for ProF 001 (ProFem website, April 2017)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top